Reviewer #3 (Public Review):
The manuscript by Scinicariello and collaborators examines the mechanisms regulating the cellular accumulation of the RNA-binding protein Tristetraprolin (TTP). This factor is a well-described regulator of mRNA stability. TTP binds to RNA AU-rich sequences localized in mRNA 3'Untranslated regions. As AU-rich elements are abundant in mRNA encoding pro-inflammatory factors, TTP has been described as a negative regulator of the inflammatory response.
Previous reports have described that the cellular level of TTP is modulated by phosphorylation and proteasome-dependent process (see several references in the introduction of the manuscript). Non-degradative phosphorylation-dependent ubiquitination of TTP has also been reported (Schichl et al. 2011 JBC 286:38466). This publication is not cited in the current version of the manuscript. The results of Schichl et al. seem particularly relevant for the interpretation of some of the results presented here and should be considered in the final discussion and conclusions of the present work.
In the first part of the results section, Scinicariello et al. evaluate the degradation and ubiquitination of TTP and conclude that TTP is degraded in a ubiquitin-dependent manner. By a pharmacological approach, they observed, as previously shown, that endogenous TTP is degraded by the proteasome (Fig1a). They also show that an overexpressed tagged version of TTP is degraded by the proteasome and ubiquitinated on lysine residues (Fig. 1B, C). The general conclusion of this paragraph seems premature in relation to the results presented. The ubiquitination of endogenous TTP has not been demonstrated. The type of ubiquitination detected on the overexpressed version of TTP is not characterized. This seems important in view of the results of Schichl et al. who showed non-degradative ubiquitination (K63) of TTP. The half-life of the non-ubiquitinated mutant of TTP (K→R) was not precisely compared to the half-life of the wild-type TTP protein (similar to the experiment presented in 1B). The effect of the E1 ubiquitin ligase TAk-243 on endogenous TTP levels was not tested.
In the second part, the authors identified the E3 ligase HUWE1 as a major determinant of cellular TTP protein abundance. This demonstration is first based on the identification of HUWE1 in an unbiased CRISPR/cas9 screen to identify modulators of mCherry-TTP fusion reporter accumulation upon activation of RAW 264.7 cells by LPS. While they demonstrate that TTP-HA is efficiently degraded after 3 to 7h of LPS stimulation (Fig 1B) and that the stronger decrease in mCherry-TTP fusion level occurs between 4 and 6h of LPS stimulation the screen for identification of TTP modulators is performed 16h of LPS stimulation (Fig 2A). The rationale behind this experimental setting is not explicitly described. Nevertheless, the authors convincingly demonstrate that HUWE1 is involved in the controls of TTP cellular abundance. This demonstration mainly relies on the fact that HUWE1 inactivation induced a strong increase of both mCherry-TTP fusion and endogenous TTP (Fig. 2B and C). Ablation of HUWE1 selectively decreases the abundance of a limited number of proteins including TTP (Fig. 5A). The specificity of Huwe1 effect is confirmed by the detection of a constant level of the co-expressed BFP protein upon HUWE1 depletion (fig sup. 2E). The effect of HUWE1 depletion on TTP accumulation is observed in different cell lines and primary cells (murine, human) (Fig. sup. 2G, Fig2F).<br /> In this paragraph, the demonstration that Huwe1 specifically affects the stability of TTP protein appears less robust. The authors did not directly test the effect of HUWE1 inactivation on endogenous TTP accumulation after blocking protein synthesis. This control seems important as data presented in figure 2E could result both from an effect of Huwe1 level on LPS-induced TTP synthesis and TTP degradation.
In the data presented in figure 2, it is not entirely clear what exactly the authors are referring to as "endogenous TTP". In Figure 2C endogenous TTP is detected by western blot on cells transfected with an mCherry-TTP fusion. In this case, the size difference allows unambiguous identification of the endogenous form of TTP (although one could not exclude that overexpressing a TTP fusion protein might affect the level of the endogenous protein). However, TTP and mCherry-TTP cannot be distinguished by FACS (Fig2 D and E). If cells used in the experiments shown in 2C and 2D-E are distinct, this should be mentioned more explicitly in the legend of Fig. 2. Otherwise, the detection of endogenous TTP should be performed on cells that do not express mCherry-TTP.
The third part of the manuscript aims to demonstrate that loss of Huwe1 decreases the half-life of pro-inflammatory mRNAs controlled by TTP. In my opinion, this conclusion is reliably supported by the data presented in Figure 3 and Supplementary Figure 3. As the conclusion of this paragraph refers to the effect of TTP on the stability of these mRNAs, the measurement of TNF mRNA stability (Fig. sup. 3C) should be presented in the main part of Fig. 3.
The authors then aim to demonstrate that HUWE1 regulates TTP phosphorylation and its increase is responsible for increased TTP stability. Taken together, data from fig. 1F, 2C, and 2F clearly show that a phosphorylated form of TTP is accumulated in Huwe1 deficient cells. The authors state that Fig 4E aims to identify kinases and phosphatases potentially involved in TTP stability (line 277, line 298). However, the approach used here (a measure of intracellular TTP level) cannot distinguish between increased production of TTP or a decrease in TTP degradation. Also, the result presented in fig. 4E, are not totally consistent with the results presented in 4A. Fig4D shows a similar level of endogenous TTP accumulating after 2h of LPS stimulation in Huwe1 KO and control cells while a clear difference in TTP level is observable in the same condition in fig. 4A. Could the difference in the TTP detection method (Western vs intracellular FACS) be responsible for this discrepancy? In addition, the absence of positive control for the various pharmacological treatments renders difficult the interpretation of these results, especially when the inhibitor shows no effect on TTP level (ex: CalyculinA). On this basis, the authors' conclusions for this paragraph seem partially over-interpreted.
From the data presented in figure 5, the authors conclude that HUWE1 controls only a small fraction of proteasome targets and regulates the stability of TTP paralog ZFP36L1.<br /> A comparison of protein levels in Huwe1 and Psmb7 Ko cells reveals that Huwe1 ablation significantly changes the concentrations of only a limited number of proteins (Fig. 5A). The reliability of these data is confirmed by the identification as increased proteins in the huwe1 ko of factors previously identified as targets of HUWE1 (Fig. sup. 5C). These experiments and data presented in Fig.5D show that the level of the TTP paralog ZFP36L1 accumulates in huwe1 KO cells but do not demonstrate that HUWE1 affects ZFP36L1 protein stability.
The next conclusion of the manuscript describes residues in the TTP234-278 region as important for their stability. Based on data presented in fig. 6 B and sup. 6B the authors conclude that residues S52 and 178, previously identified as regulators of TTP stability, are unlikely to be involved in HUWE1-dependent TTP accumulation. The data are only based on 2 independent experiments, one of which (fig 6B) shows a difference in TTP S52/S178 mutant in Huwe1 deficient cells as compared to wt TTP. These results seem therefore too preliminary to reliably exclude the implication of S52 and 178 on the HUWE1 accumulation of TTP.
Other data from Fig. 6 further analyze the effect of deleting different regions of the TTP protein on the accumulation of this factor in HUWE1 KO and control cells. From these data, the authors conclude (line 416) that N-terminal deletion does not affect the TTP protein level. However, TTP accumulation in Huwe1 KO cells seems mostly lost in mutant N4. As mentioned above the limited number of replicates (n=2) and the absence of a statistical test makes the interpretation of this result difficult.
Several TTP C-terminal mutants show a HUWE1-independent accumulation when compared to the wt protein (Fig6. D). Is this region identical to the unstructured region identified by Ngoc (line 1255) as a potent regulator of TTP degradation? If relevant this point should be discussed.